Abiopharma

🔍 Ritchie Robert C (Executive)

Company: American Integrity Insurance Group, Inc. (AII)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 12,000 shares of Common Stock at $25.34 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 2,139,611.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 6,000 shares of Common Stock at $25.24 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 2,133,611.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.
• F2: The price reported is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $25.09 to $25.63, inclusive. The reporting person undertakes to provide to American Integrity Insurance Group, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold in the transactions at each separate price within the range set forth in this footnote.
• F3: The price reported is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $24.73 to $25.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold in the transactions at each separate price within the range set forth in this footnote.